salicylic acid and pyrimidinones

salicylic acid has been researched along with pyrimidinones in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Anderson, GS; Bilitz, JM; Krieg, M; Sieber, F; Traul, DL1
Anderson, MS; Feix, JB; Kalyanaraman, B2
Green, JS; Norris, DA; Wisell, J1
Hida, T; Horimoto, K; Kato, J; Minowa, T; Sato, S; Sawada, M; Takahashi, H; Uhara, H1
Chalk, C; Elkrief, A; Falet, JR; Zaloum, A1

Other Studies

6 other study(ies) available for salicylic acid and pyrimidinones

ArticleYear
Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs.
    Photochemistry and photobiology, 1995, Volume: 62, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Transplantation; Drug Synergism; Female; Hematopoietic Stem Cells; Leukemia L1210; Light; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Oxygen; Photochemotherapy; Photosensitizing Agents; Pyrimidinones; Salicylates; Salicylic Acid; Serum Albumin, Bovine; Singlet Oxygen; Tumor Cells, Cultured

1995
Enhancement of merocyanine 540 uptake and photodynamic cell killing by salicylates.
    Cancer research, 1994, Jul-01, Volume: 54, Issue:13

    Topics: Animals; Benzoates; Benzoic Acid; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Fluorescence; Humans; Leukemia; Leukemia L1210; Mice; Neoplasms; Photochemotherapy; Photosensitizing Agents; Pyrimidinones; Salicylates; Salicylic Acid

1994
Enhancement of merocyanine 540-mediated phototherapy by salicylate.
    Cancer research, 1993, Feb-15, Volume: 53, Issue:4

    Topics: Animals; Cell Survival; Drug Synergism; Gentisates; Humans; Hydroxides; Hydroxybenzoates; Hydroxyl Radical; Leukemia; Leukemia L1210; Oxygen; Photochemotherapy; Photosensitizing Agents; Pyrimidinones; Salicylates; Salicylic Acid

1993
Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases.
    The British journal of dermatology, 2013, Volume: 169, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Head and Neck Neoplasms; Humans; Imidazoles; Male; MAP Kinase Kinase Kinases; Melanoma; Middle Aged; Mutation; Neoplasm Metastasis; Oximes; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Scalp; Skin Neoplasms

2013
Granulocyte colony-stimulating factor-producing melanoma treated with the combination of dabrafenib and trametinib.
    International journal of dermatology, 2018, Volume: 57, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Imidazoles; Male; Melanoma; Oximes; Pyridones; Pyrimidinones; Scalp; Skin Neoplasms

2018
Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma.
    Neurology, 2020, 02-18, Volume: 94, Issue:7

    Topics: Aged; Antineoplastic Agents; Humans; Imidazoles; Male; Melanoma; Myasthenia Gravis; Neoplasm Metastasis; Oximes; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Scalp; Skin Neoplasms

2020